192 related articles for article (PubMed ID: 28984022)
1. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
Matsumoto Y; Kadono T; Matsuoka M; Kawakami T; Furuya N; Doi M; Hoshikawa M; Soma Y
J Dermatol; 2018 Feb; 45(2):e33-e34. PubMed ID: 28984022
[No Abstract] [Full Text] [Related]
2. Multiple erosive lichen planus preceded by solitary lichen planus after combination therapy with nivolumab and radiation.
Komori T; Honda T; Irie H; Otsuka A; Kabashima K
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e382-e384. PubMed ID: 28295693
[No Abstract] [Full Text] [Related]
3. Nivolumab-induced lichen planus pemphigoides.
Strickley JD; Vence LM; Burton SK; Callen JP
Cutis; 2019 Apr; 103(4):224-226. PubMed ID: 31116807
[TBL] [Abstract][Full Text] [Related]
4. Linear bullous lichen planus associated with nivolumab.
Biolo G; Caroppo F; Salmaso R; Alaibac M
Clin Exp Dermatol; 2019 Jan; 44(1):67-68. PubMed ID: 29920744
[No Abstract] [Full Text] [Related]
5. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
Sato Y; Fujimura T; Mizuashi M; Aiba S
J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
[No Abstract] [Full Text] [Related]
6. Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
Coscarart A; Martel J; Lee MP; Wang AR
J Cutan Pathol; 2020 Mar; 47(3):275-279. PubMed ID: 31589773
[TBL] [Abstract][Full Text] [Related]
7. Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine.
Headd VA; Mathien A; Pei S; Kuraitis D
Australas J Dermatol; 2024 Jun; 65(4):e97-e99. PubMed ID: 38337182
[No Abstract] [Full Text] [Related]
8. Mucosal Lichen Planus Mimicking Mucosal Lesions in Stevens-Johnson Syndrome after Nivolumab Therapy.
Miyagawa F; Nakajima A; Ohyama SI; Aoki Y; Nishikawa M; Nakamura Y; Hashimoto T; Asada H
Acta Derm Venereol; 2019 Jun; 99(7):687-688. PubMed ID: 30938822
[No Abstract] [Full Text] [Related]
9. Generalized Lichen Nitidus Following Anti-PD-1 Antibody Treatment.
Cho M; Nonomura Y; Kaku Y; Dainichi T; Otsuka A; Kabashima K
JAMA Dermatol; 2018 Mar; 154(3):367-369. PubMed ID: 29344609
[No Abstract] [Full Text] [Related]
10. Histologically-diagnosed psoriasiform dermatitis induced by nivolumab successfully controlled by etanercept: A case report.
Kim YE; Kim TM; Jo SJ
J Dermatol; 2019 Dec; 46(12):e464-e466. PubMed ID: 31531885
[No Abstract] [Full Text] [Related]
11. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
[No Abstract] [Full Text] [Related]
12. Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab.
Feldstein SI; Patel F; Larsen L; Kim E; Hwang S; Fung MA
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):e58-e59. PubMed ID: 28776778
[No Abstract] [Full Text] [Related]
13. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.
Shah RR; Bhate C; Hernandez A; Ho CH
Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258
[TBL] [Abstract][Full Text] [Related]
14. Sweat gland abnormalities in lichenoid dermatosis.
Akosa AB; Lampert IA
Histopathology; 1991 Oct; 19(4):345-9. PubMed ID: 1834538
[TBL] [Abstract][Full Text] [Related]
15. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
Andrés-Lencina JJ; Burillo-Martínez S; Aragón-Miguel R; Calleja-Algarra A; Rodríguez-Peralto JL; Ortiz-Romero PL; Gargallo-Moneva V
Australas J Dermatol; 2018 Nov; 59(4):e302-e304. PubMed ID: 29797309
[No Abstract] [Full Text] [Related]
17. Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions.
Reschke R; Mockenhaupt M; Simon JC; Ziemer M
J Dtsch Dermatol Ges; 2019 Sep; 17(9):942-948. PubMed ID: 31210413
[No Abstract] [Full Text] [Related]
18. Carbamazepine-induced lichenoid eruption.
Atkin SL; McKenzie TM; Stevenson CJ
Clin Exp Dermatol; 1990 Sep; 15(5):382-3. PubMed ID: 2146051
[TBL] [Abstract][Full Text] [Related]
19. Crizotinib-induced lichenoid drug eruption in a patient with lung cancer.
Ho YH; Chen CL
Cutis; 2018 Dec; 102(6):403-406. PubMed ID: 30657798
[TBL] [Abstract][Full Text] [Related]
20. Lichenoid drug eruption secondary to propranolol.
Massa MC; Jason SM; Gradini R; Welykyj S
Cutis; 1991 Jul; 48(1):41-3. PubMed ID: 1831116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]